Seouleaguer Co., Ltd.

A043710

KR7043710003

Drug Retailers

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
575 ^KRW	+2.68%		+2.86%	-22.19%

Mar. 21	SEOULEAGUER Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SEOULEAGUER Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Seouleaguer Co., Ltd. announced that it has received KRW 15.02 billion in funding

June 26, 2018

On June 27, 2018, Seouleaguer Co., Ltd. (KOSDAQ:A043710) closed the transaction.

Latest news about Seouleaguer Co., Ltd.

SEOULEAGUER Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
SEOULEAGUER Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Seouleaguer Co., Ltd. announced that it has received KRW 9.9999998 billion in funding from Sesim Co., Ltd.	22-12-08	CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
Seouleaguer Co., Ltd. announced that it has received KRW 9.9999998 billion in funding from Sesim Co., Ltd.	22-08-11	CI
Seouleaguer Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 9.9999998 billion in funding from Sesim Co., Ltd.	22-03-13	CI
Seouleaguer Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Seouleaguer Co., Ltd. cancelled the acqusition of 50% stake in Look Optics Co., Ltd. From Neoplux No.1 Private Equity Fund, managed by Neoplux Co., Ltd.	20-06-19	CI
Seouleaguer Co., Ltd. announced that it has received KRW 5 billion in funding	20-02-02	CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 5 billion in funding	20-01-16	CI
Air Premia Inc. announced that it has received KRW 5.193531 billion in funding from Seouleaguer Co., Ltd.	19-07-21	CI
Seouleaguer Co., Ltd. agreed to acquire 50% stake in Look Optics Co., Ltd. From Neoplux No.1 Private Equity Fund, managed by Neoplux Co., Ltd., for KRW 16.7 billion.	19-06-19	CI
Seouleaguer Co., Ltd. announced that it has received KRW 10.01 billion in funding from Sesim Co., Ltd., Hwa Ui Co., Ltd.	19-05-29	CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 10.01 billion in funding from Sesim Co., Ltd., Hwa Ui Co., Ltd.	19-05-21	CI
Seouleaguer Co., Ltd. announced that it has received KRW 13 billion in funding from Seouleaguer Cosmetics Co Ltd	18-12-26	CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 13 billion in funding from Seouleaguer Cosmetics Co Ltd and other investors	18-12-06	CI
Seouleaguer Co., Ltd. announced that it has received KRW 15.02 billion in funding	18-06-26	CI
Seouleaguer Co., Ltd. announced that it expects to receive KRW 15.02 billion in funding	18-06-17	CI
Misan Partners Co., Ltd. acquired an additional 0.28% stake in Seouleaguer Co., Ltd. from Sungjee Construction Co., Ltd. for approximately KRW 250 million.	17-03-05	CI
Seouleaguer Partners Co. Ltd., Sungjee Construction Co., Ltd., Kibo Choi, Hyeim Lee, Eunchang Byun, and Hyunju Song acquired 12.45% stake in Seouleaguer Co., Ltd. from HSB Company Co., Ltd.	16-12-13	CI

SEOULEAGUER CO., LTD, formerly ROCKETMOBILE CO., LTD, is a Korea-based company principally engaged in the drug sales business. The Company operates its business through four segments. The Healthcare Business segment distributes medicines and cosmetics. The Management Service Organization (MSO) Business segment involves in the advertising and real estate lease business. The Medical Business segment provides medical services such as skin care. The Mobile Accessory segment offers mobile accessories and peripherals including cases, cradles, chargers, bluetooth and others.

Sector

Drug Retailers

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
SEOULEAGUER CO., LTD.	-22.19%	21.33M
JD HEALTH INTERNATIONAL INC.	-20.84%	12.31B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-24.53%	6.59B
YIFENG PHARMACY CHAIN CO., LTD.	+12.51%	6.3B
MATSUKIYOCOCOKARA & CO.	-8.87%	5.88B
NAHDI MEDICAL COMPANY	-0.73%	4.74B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+60.03%	4.7B
CLICKS GROUP LIMITED	-4.98%	4.03B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-8.76%	3.58B
WELCIA HOLDINGS CO., LTD.	-7.32%	3.07B

Other Drug Retailers